Search Results 1291-1300 of 19900 for Receptor

1. Cough Clinic employs novel pharmacologics to address unexplained or refractory chronic cough - Mayo Clinic

   Hoskote continues: "The future of unexplained chronic cough management holds a number of novel pharmacologic options that focus on various receptor targets in ...

2. Meet The Faculty - Autoimmune Neurology Fellowship (Florida) - Mayo Clinic College of Medicine & Science

   He is a founding member and Clinical Director of the Anti-NMDA Receptor Encephalitis FoundationOpens in new tab , and a project PI of the ExTINGUISH Trial ...

3. Antibody Treatment for Advanced Celiac Disease - Mayo Clinic

   ... receptor and monoclonal antibody studies performed; this could facilitate identification of cases of adult-onset autoimmune enteropathy and those of cryptic ...

4. Selection Of Allogeneic Hematopoietic Cell Donors Based On KIR And HLA Genotypes - Mayo Clinic

   There is published data to show that donors with specific other genes called killer immunoglobulin-like receptors (KIR) may protect AML patients from having ...

5. Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Prior treatment with enzalutamide or other potent androgen-receptor blockers, approved or experimental (e.g., ARN-509, ODM-201, or galeterone). Prior ...

6. Living With Cancer: Understanding HER2-positive breast cancer - Mayo Clinic News Network

   HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), which promotes the ...

7. A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer - Mayo Clinic

   Estrogen Receptor (ER)-, Progesterone Receptor (PR)-, and Human Epidermal Growth Factor Receptor (HER)2-negative (triple-negative) cancer of the breast.

8. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

   Administration of thrombopoietin receptor agonists when the dose has NOT been stable within 3 weeks before enrollment and a dosage change is planned before Day ...

9. Attack the Gap-New Immunotherapy May Help the Body Fight Ovarian Cancer

   The phase I trial targets a specific protein, folate receptor alpha, in the cancer cells. It also uses a specific type of T cell, Th17, to trigger an immune ...

10. High blood pressure and cold remedies: Which are safe? - Mayo Clinic

    Angiotensin II receptor blockers · Angiotensin-converting enzyme (ACE) inhibitors · Anxiety: A cause of high blood pressure? Arteriosclerosis / atherosclerosis ...